Advierten riesgo de desatención médica en los CAPASITS imparcialoaxaca.mx - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from imparcialoaxaca.mx Daily Mail and Mail on Sunday newspapers.
It's one of the largest expansions Compass Community Center has witnessed in over 30 years. On Friday, the center partnered with CAN Community Health to provide on-site doctors and other immediate services to people who test positive for HIV.
Billy Porter announces he is HIV positive as he breaks 14-year silence
Broadway star and Emmy winner Billy Porter, 51, has bravely spoken about his truth for the first time since he was diagnosed in 2007
Updated
Sign up!
When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
Billy Porter has revealed that he is HIV positive as he opened up about hiding his condition for 14 years from co-stars out of shame .
The Broadway star and Emmy winner, 51, has bravely spoken about his truth for the first time since he was diagnosed in 2007.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
CytoDyn Executes Exclusive Supply and Distribution Agreement with Chiral Pharma Corporation to .
CytoDyn Inc.April 15, 2021 GMT
Under Compassionate Special Permit (CSP) in Philippines, CytoDyn is well positioned to generate significant revenues
VANCOUVER, Washington., April 15, 2021 (GLOBE NEWSWIRE) CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with potential multiple therapeutic indications, announced today it has executed an exclusive supply and distribution agreement with Chiral Pharma Corporation to supply up to 200,000 vials of leronlimab to critically ill COVID-19 patients in the Philippines under CSP authorizations. This agreement will accelerate the delivery of leronlimab upon an expanded authorization under CSP.